Mega Aid Compounding Pharmacy, founded in 2007, is a PCAB/ACHC-accredited compounding pharmacy that offers multi-modal compound treatments and medication therapy management. The company's slogan "Multi-modal compound treatments and medication therapy management | Pain management, dermatology solutions and more" reflects its commitment to tailored medicines and continuous health monitoring for improved patient outcomes. Specializing in a wide range of conditions including arthritis/inflammation, neuropathy, hair loss, fungus, dermatology, skin pigmentation, bioidentical hormone replacement, sexual dysfunction, behavioral health, depression, and hemorrhoids, Mega Aid serves the medical community and their patients in all five boroughs of New York City and across New York State. Operating in the pharmaceutical industry, the company has not disclosed its headquarters or information about its last_investment and last_investment_investors. Nevertheless, Mega Aid's focus on personalized medicine and comprehensive health management presents a compelling proposition for potential investors seeking opportunities in the pharmaceutical and healthcare sectors.
There is no investment information
No recent news or press coverage available for Mega Aid Compounding Pharmacy.